Indication

Ornithine carbamoyltransferase deficiency

Ornithine carbamoyltransferase deficiency is an X-linked inborn error of metabolism and the most common disorder of the urea cycle. Read more about Ornithine carbamoyltransferase deficiency

41 drugs 28 manufacturers

Advertisement

Drugs that treat it

Common Ornithine carbamoyltransferase deficiency therapies.

Showing 10–18 of 41 drugs

Filter & compare in the drug finder →Opens the drug finder with Ornithine carbamoyltransferase deficiency preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Ornithine carbamoyltransferase deficiency.

Ornithine carbamoyltransferase deficiency is an X-linked inborn error of metabolism and the most common disorder of the urea cycle.

It is caused by pathogenic variants in the *OTC* gene, leading to deficient mitochondrial ornithine carbamoyltransferase activity and the failure to convert carbamoyl phosphate and ornithine into citrulline.

This enzymatic block primarily affects the hepatic urea cycle and central nervous system, resulting in the systemic accumulation of neurotoxic ammonia and excessive urinary excretion of orotic acid.

Clinical manifestations range from catastrophic neonatal hyperammonemic encephalopathy, lethargy, seizures, and coma in hemizygous males to late-onset episodic confusion, psychiatric disturbances, or developmental delay across childhood and adulthood in individuals with partial enzyme deficiency or skewed X-inactivation.

Personalize your experience

Follow Ornithine carbamoyltransferase deficiency and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it